ESC2025 Premium Access

Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM

Congress Presentation

About the speaker

Doctor Sara Saberi

University of Michigan Hospital, Ann Arbor (United States of America)
1 presentation
0 follower

7 more presentations in this session

Physical activity measured by accelerometry in hypertrophic cardiomyopathy: findings from the AFFECT-HCM study

Speaker: Doctor S. Schoonvelde (Rotterdam, NL)

Thumbnail

Re-classification of hypertrophic cardiomyopathy genetic variants in patients from the sarcomeric human cardiomyopathy registry (SHaRe)

Speaker: Ms S. Hespe (Sydney, AU)

Thumbnail

Minimally invasive electro septal myectomy for hypertrophic obstructive cardiomyopathy via right infra-axillary incision

Speaker: Professor Y. Cui (Hangzhou, CN)

Thumbnail

Mavacamten treatment in obstructive hypertrophic cardiomyopathy for up to 30 weeks: An integrated analysis of cardiac magnetic resonance data from a diverse population in randomized clinical trials

Speaker: Doctor C. Kramer (Charlottesville, US)

Thumbnail

Worse prognosis for sudden cardiac death events and progression to the burned-out phase in non-obstructive hypertrophic cardiomyopathy: insights from the REVEAL-HCM Registry

Speaker: Doctor A. Kimura (Okayama, JP)

Thumbnail

Access the full session

Hypertrophic cardiomyopathy: from gene to treatment

Speakers: Doctor S. Saberi, Doctor S. Schoonvelde, Ms S. Hespe, Professor Y. Cui, Doctor C. Kramer...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations